Welcome to our dedicated page for Piper Sandler Co`S SEC filings (Ticker: PIPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Piper Sandler Companies (NYSE: PIPR) SEC filings page on Stock Titan brings together the firm’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered summaries to help interpret them. As an investment bank and institutional securities firm, Piper Sandler uses SEC filings to report its financial results, describe its operations and comply with ongoing reporting obligations.
Recent Form 8-K filings for Piper Sandler reference Item 2.02 – Results of Operations and Financial Condition, noting the release of financial results for specific fiscal quarters and directing readers to accompanying press releases furnished as exhibits. These current reports complement the firm’s earnings announcements and conference calls, providing an official record of quarterly performance.
On this page, you can access Piper Sandler’s 8-K current reports and, where available, annual reports on Form 10-K, quarterly reports on Form 10-Q, and other relevant filings. Stock Titan’s AI features are designed to highlight key sections, explain technical language and surface important points about advisory and capital markets activities, segment performance and risk disclosures as presented by the company in its filings.
For users interested in governance and ownership information, this page also serves as a starting point to locate proxy materials and insider transaction reports such as Form 4, when filed. Real-time updates from EDGAR combined with AI-generated overviews can help investors and researchers quickly understand what Piper Sandler reports in each document, without reading every page in detail.
Piper Sandler Companies appointed Stuart M. Essig to its Board of Directors effective February 4, 2026, for an initial term ending at the 2026 annual meeting of shareholders. His election increases the Board size from nine to ten directors, and he will serve on the Audit Committee.
Essig previously served as chief executive officer of Integra LifeSciences Corporation from 1997 to 2012 and has been chairman of its board since 2012, including as executive chairman from 2024 to 2025. He is also a director of IDEXX Laboratories. For his Board service in 2026, he will receive a prorated $100,000 cash retainer, a $60,000 initial equity grant, and a $150,000 annual equity grant after the 2026 annual shareholders’ meeting.
The Vanguard Group filed an amended Schedule 13G reporting beneficial ownership of 2,128,150 shares of Piper Sandler Cos common stock, representing 12.03% of the class as of 12/31/2025. Vanguard reports shared voting power over 140,426 shares and shared dispositive power over all 2,128,150 shares, with no sole voting or dispositive power.
The filing explains that Vanguard’s clients, including registered investment companies and other managed accounts, have the right to receive dividends and sale proceeds on these shares, with no single client holding more than 5% of the class. Vanguard states the holdings are in the ordinary course of business and not for the purpose of changing or influencing control. It also notes an internal realignment effective 01/12/2026, after which certain subsidiaries may report beneficial ownership on a disaggregated basis.
Piper Sandler Companies executive Jean-Paul M. Peltier, Global Co-Head IB and Cap Mkts, has filed an initial ownership report. The Form 3 shows that he beneficially owns 36,024 shares of Piper Sandler common stock, held in direct form. The reporting date for this ownership position is 01/09/2026. This is a disclosure of existing holdings rather than a record of a new stock purchase or sale.
Piper Sandler Companies director defers fees into stock units
A director of Piper Sandler Companies reported a routine compensation-related transaction. On 12/31/2025, the director accrued 75 shares of phantom stock at a price of $0 by electing to defer quarterly director cash retainer fees into stock-based units instead of taking cash. After this transaction, the director beneficially owned 25,525 shares of Piper Sandler common stock in total on a direct basis.
The phantom stock will be paid out in Piper Sandler common shares on the last day of the year in which the director’s board service ends, aligning part of the director’s compensation with the company’s long-term share performance.
Piper Sandler Companies director Philip E. Soran reported a routine change in his holdings. On 12/31/2025, he acquired 75 shares of phantom stock at a price of $0, reflecting his election to defer quarterly director cash retainer fees.
After this transaction, he beneficially owned 19,330 shares of common stock in total. The 75 phantom shares will be paid out in Piper Sandler common stock on the last day of the year in which his service as a director ends.
Piper Sandler Companies director reports deferred-fee stock accrual
A director of Piper Sandler Companies reported a transaction dated 12/31/2025 involving company common stock. The filing shows the director acquired 75 shares of common stock at a price of $0, bringing her total directly owned common shares to 1,349 after the transaction.
According to the explanation, the director elected to defer quarterly director cash retainer fees, which resulted in the accrual of 75 shares of phantom stock to her account. These phantom shares are to be paid out in common stock on the last day of the year in which her service as a director ends.
Piper Sandler Companies director reported an insider equity transaction involving the company’s common stock. On 12/12/2025, the director acquired 6 additional shares at a price of $ 0 per share, bringing total beneficial ownership to 25,450 shares held directly.
The filing explains that dividend equivalents paid on shares of phantom stock in the directors' deferred compensation plan are deemed reinvested in additional phantom shares. These phantom stock amounts become payable in an equal number of shares of common stock on the last day of the year in which the director’s service as a board member terminates.
Piper Sandler Companies director Philip E. Soran reported an automatic acquisition of 38 shares of common stock on 12/12/2025 at a price of $0 per share, bringing his directly held stake to 19,255 shares. The filing explains that dividend equivalents paid on phantom stock are reinvested into additional phantom shares under the directors' deferred compensation plan, which become payable in an equal number of common shares on the last day of the year in which his service as a director ends.
Piper Sandler Companies director Scott C. Taylor received 16 shares of common stock on 12/12/2025 through a deferred compensation plan transaction at a price of $0.
The filing shows his beneficial ownership rising to 16,352 common shares held directly. The additional shares reflect dividend equivalents on phantom stock that are automatically reinvested in more phantom shares.
According to the plan, these phantom shares become payable in an equal number of common shares on the last day of the year in which his service as a director ends.
Piper Sandler Companies disclosed an insider equity transaction by a director tied to the company’s deferred compensation plan. On 12/12/2025, 7 shares of phantom stock were credited as dividend equivalents, which are designed to be reinvested and track the value of common stock.
These phantom shares accrue in the director’s deferred compensation account and will be settled in an equal number of common shares when the director’s board service ends. Following this transaction, the reporting person beneficially owned 3,391 shares of common stock directly.